← Open Payments lookup

BASSAM AWWA: Open Payments

NPI 1881774354 · NEW LONDON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,200 in 190 payments from 18 companies in 2025. Trend: 2023 $14,815 · 2024 $3,381 · 2025 $4,200

Food & beverage: $4,200
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.25$598
Janssen Pharmaceuticals, Inc12$529
Axsome Therapeutics, Inc.27$430
Vanda Pharmaceuticals Inc.12$384
ABBVIE INC.25$341
Supernus Pharmaceuticals, Inc.19$304
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$219
Teva Pharmaceuticals USA, Inc.7$213
Takeda Pharmaceuticals U.S.A., Inc.8$189
Corium, LLC9$177

Products named: COBENFY, SPRAVATO, FANAPT, VRAYLAR, Qelbree, Sunosi, CAPLYTA, REXULTI.

Industry payments across CT — which companies pay providers there.